“Monoclonal Antibody Against CGRP (TEV-48125) for Preventive Treatment of Episodic Cluster Headache: A Phase II Randomized Clinical Trial Protocol”. Principles and Practice of Clinical Research, vol. 4, no. 1, July 2018, pp. 14-20, https://journal.ppcr.org/index.php/ppcrjournal/article/view/53.